Header Logo

Mark H Pollack

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentAdult Psychiatry
Address1645 W. Jackson Blvd.
Chicago IL 60612
Phone312-942-5372
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 7201625274.
    My NIH COMMONS name is MPOLLACK.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Taylor CT, Rosenfield D, Dowd SM, Dutcher CD, Hofmann SG, Otto MW, Pollack MH, Smits JAJ. What good are positive emotions for treatment? A replication test of whether trait positive emotionality predicts response to exposure therapy for social anxiety disorder. Behav Res Ther. 2023 12; 171:104436. PMID: 37979218.
      Citations:    
    2. Lubin RE, Fitzgerald HE, Rosenfield D, Carpenter JK, Papini S, Dutcher CD, Dowd SM, Hofmann SG, Pollack MH, Smits JAJ, Otto MW. Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT. J Psychiatr Res. 2023 08; 164:357-363. PMID: 37399757.
      Citations:    
    3. Sung SC, Lim L, Lim SH, Finkelstein EA, Chin SLH, Annathurai A, Chakraborty B, Strauman TJ, Pollack MH, Ong MEH. Protocol for a multi-site randomized controlled trial of a stepped-care intervention for emergency department patients with panic-related anxiety. BMC Psychiatry. 2022 Dec 16; 22(1):795. PMID: 36527018.
      Citations:    
    4. Dutcher CD, Dowd SM, Zalta AK, Taylor DJ, Rosenfield D, Perrone A, Otto MW, Pollack MH, Hofmann SG, Smits JAJ. Sleep quality and outcome of exposure therapy in adults with social anxiety disorder. Depress Anxiety. 2021 11; 38(11):1182-1190. PMID: 34010494.
      Citations:    
    5. Dowd SM, Zalta AK, Burgess HJ, Adkins EC, Valdespino-Hayden Z, Pollack MH. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World J Psychiatry. 2020 Mar 19; 10(3):21-28. PMID: 32257848.
      Citations:    
    6. Miller ML, Bagley JM, Normand P, Brennan MB, Van Horn R, Pollack MH, Held P. Increasing Mindfulness Skills of Veterans With PTSD Through Daily Mindfulness Training Incorporated Into an Intensive Treatment Program. Mindfulness (N Y). 2021 Apr; 11(4):964-974. PMID: 34367355.
      Citations:    
    7. Tirone V, Smith D, Steigerwald VL, Bagley JM, Brennan M, Van Horn R, Pollack M, Held P. Examining the Impact of Sexual Revictimization in a Sample of Veterans Undergoing Intensive PTSD Treatment. J Interpers Violence. 2021 12; 36(23-24):10989-11008. PMID: 31898925.
      Citations:    
    8. Thompson HM, Hill K, Jadhav R, Webb TA, Pollack M, Karnik N. The Substance Use Intervention Team: A Preliminary Analysis of a Population-level Strategy to Address the Opioid Crisis at an Academic Health Center. J Addict Med. 2019 Nov/Dec; 13(6):460-463. PMID: 31689260.
      Citations:    
    9. Held P, Klassen BJ, Boley RA, Wiltsey Stirman S, Smith DL, Brennan MB, Van Horn R, Pollack MH, Karnik NS, Zalta AK. Feasibility of a 3-week intensive treatment program for service members and veterans with PTSD. Psychol Trauma. 2020 May; 12(4):422-430. PMID: 31318250.
      Citations:    
    10. Thompson H, Faig W, Gupta N, Lahey R, Golden R, Pollack M, Karnik N. Collaborative Care for Depression of Adults and Adolescents: Measuring the Effectiveness of Screening and Treatment Uptake. Psychiatr Serv. 2019 07 01; 70(7):604-607. PMID: 31023189.
      Citations:    
    11. Zalta AK, Bravo K, Valdespino-Hayden Z, Pollack MH, Burgess HJ. A placebo-controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 07; 36(7):617-624. PMID: 30995350.
      Citations:    
    12. Burgess HJ, Rizvydeen M, Kimura M, Pollack MH, Hobfoll SE, Rajan KB, Burns JW. An Open Trial of Morning Bright Light Treatment Among US Military Veterans with Chronic Low Back Pain: A Pilot Study. Pain Med. 2019 04 01; 20(4):770-778. PMID: 30204903.
      Citations:    
    13. Zalta AK, Held P, Smith DL, Klassen BJ, Lofgreen AM, Normand PS, Brennan MB, Rydberg TS, Boley RA, Pollack MH, Karnik NS. Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD. BMC Psychiatry. 2018 07 27; 18(1):242. PMID: 30053860.
      Citations:    
    14. Carroll KK, Lofgreen AM, Weaver DC, Held P, Klassen BJ, Smith DL, Karnik NS, Pollack MH, Zalta AK. Negative posttraumatic cognitions among military sexual trauma survivors. J Affect Disord. 2018 10 01; 238:88-93. PMID: 29864715.
      Citations:    
    15. Held P, Klassen BJ, Hall JM, Friese TR, Bertsch-Gout MM, Zalta AK, Pollack MH. "I knew it was wrong the moment I got the order": A narrative thematic analysis of moral injury in combat veterans. Psychol Trauma. 2019 May; 11(4):396-405. PMID: 29723032.
      Citations:    
    16. Zalta AK, Bui E, Karnik NS, Held P, Laifer LM, Sager JC, Zou D, Rauch PK, Simon NM, Pollack MH, Ohye B. Examining the Relationship Between Parent and Child Psychopathology in Treatment-Seeking Veterans. Child Psychiatry Hum Dev. 2018 04; 49(2):209-216. PMID: 28660407.
      Citations:    
    17. Stathopoulou G, Pollack MH, Otto MW. Anxiety sensitivity moderates drug cravings in response to induced negative affect in opioid dependent outpatients. Addict Behav. 2018 09; 84:75-78. PMID: 29631093.
      Citations:    
    18. Pollack MH, Betof A, Dearden H, Rapazzo K, Valentine I, Brohl AS, Ancell KK, Long GV, Menzies AM, Eroglu Z, Johnson DB, Shoushtari AN. Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma. Ann Oncol. 2018 01 01; 29(1):250-255. PMID: 29045547.
      Citations:    
    19. Roque AD, Rosenfield D, Smits JAJ, Simon N, Otto MW, Marques L, Pollack MH, Hofmann SG, Meuret AE. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction? J Anxiety Disord. 2018 01; 53:85-90. PMID: 29227845.
      Citations:    
    20. Held P, Klassen BJ, Zou DS, Schroedter BS, Karnik NS, Pollack MH, Zalta AK. Negative Posttrauma Cognitions Mediate the Association Between Morally Injurious Events and Trauma-Related Psychopathology in Treatment-Seeking Veterans. J Trauma Stress. 2017 12; 30(6):698-703. PMID: 29140560.
      Citations:    
    21. Pollack MH, Simon NM, Rothbaum BO. Care of Veterans Through the Warrior Care Network. Focus (Am Psychiatr Publ). 2017 Oct; 15(4):377. PMID: 31975866.
      Citations:    
    22. Held P, Boley RA, Karnik NS, Pollack MH, Zalta AK. Characteristics of veterans and military service members who endorse causing harm, injury, or death to others in the military. Psychol Trauma. 2018 May; 10(3):352-359. PMID: 28758768.
      Citations:    
    23. Mataix-Cols D, Fern?ndez de la Cruz L, Monzani B, Rosenfield D, Andersson E, P?rez-Vigil A, Frumento P, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hofmann SG, Hendriks GJ, Kushner MG, Lee FS, Lenze EJ, Levinson CA, McConnell H, Otto MW, Plag J, Pollack MH, Ressler KJ, Rodebaugh TL, Rothbaum BO, Scheeringa MS, Siewert-Siegmund A, Smits JAJ, Storch EA, Str?hle A, Tart CD, Tolin DF, van Minnen A, Waters AM, Weems CF, Wilhelm S, Wyka K, Davis M, R?ck C, Altemus M, Anderson P, Cukor J, Finck C, Geffken GR, Golfels F, Goodman WK, Gutner C, Heyman I, Jovanovic T, Lewin AB, McNamara JP, Murphy TK, Norrholm S, Thuras P. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017 05 01; 74(5):501-510. PMID: 28122091.
      Citations:    
    24. Hoge EA, Guidos BM, Mete M, Bui E, Pollack MH, Simon NM, Dutton MA. Effects of mindfulness meditation on occupational functioning and health care utilization in individuals with anxiety. J Psychosom Res. 2017 04; 95:7-11. PMID: 28314552.
      Citations:    
    25. Zalta AK, Tirone V, Siedjak J, Boley RA, Vechiu C, Pollack MH, Hobfoll SE. A Pilot Study of Tailored Cognitive-Behavioral Resilience Training for Trauma Survivors With Subthreshold Distress. J Trauma Stress. 2016 06; 29(3):268-72. PMID: 27121865.
      Citations:    
    26. Otto MW, Kredlow MA, Smits JAJ, Hofmann SG, Tolin DF, de Kleine RA, van Minnen A, Evins AE, Pollack MH. Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions. Biol Psychiatry. 2016 08 15; 80(4):274-283. PMID: 26520240.
      Citations:    
    27. Mundy EA, Weber M, Rauch SL, Killgore WD, Simon NM, Pollack MH, Rosso IM. ADULT ANXIETY DISORDERS IN RELATION TO TRAIT ANXIETY AND PERCEIVED STRESS IN CHILDHOOD. Psychol Rep. 2015 Oct; 117(2):473-89. PMID: 26340052.
      Citations:    
    28. Whitfield-Gabrieli S, Ghosh SS, Nieto-Castanon A, Saygin Z, Doehrmann O, Chai XJ, Reynolds GO, Hofmann SG, Pollack MH, Gabrieli JD. Brain connectomics predict response to treatment in social anxiety disorder. Mol Psychiatry. 2016 May; 21(5):680-5. PMID: 26260493.
      Citations:    
    29. Hofmann SG, Carpenter JK, Otto MW, Rosenfield D, Smits JA, Pollack MH. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale. Contemp Clin Trials. 2015 Jul; 43:223-30. PMID: 26111923.
      Citations:    
    30. Pollack MH, Stein M, Simon N, Van Ameringen M. Response to Silberman. Am J Psychiatry. 2014 Jul; 171(7):795-6. PMID: 24980175.
      Citations:    
    31. Hoge EA, Bui E, Marques L, Metcalf CA, Morris LK, Robinaugh DJ, Worthington JJ, Pollack MH, Simon NM. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013 Aug; 74(8):786-92. PMID: 23541163.
      Citations:    
    32. Bui E, Orr SP, Jacoby RJ, Keshaviah A, LeBlanc NJ, Milad MR, Pollack MH, Simon NM. Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals. Hum Psychopharmacol. 2013 Sep; 28(5):447-56. PMID: 23776033.
      Citations:    
    33. Aderka IM, Pollack MH, Simon NM, Smits JA, Van Ameringen M, Stein MB, Hofmann SG. Development of a brief version of the Social Phobia Inventory using item response theory: the Mini-SPIN-R. Behav Ther. 2013 Dec; 44(4):651-61. PMID: 24094790.
      Citations:    
    34. Marques L, Porter E, Keshaviah A, Pollack MH, Van Ameringen M, Stein MB, Simon NM. Avoidant personality disorder in individuals with generalized social anxiety disorder: what does it add? J Anxiety Disord. 2012 Aug; 26(6):665-72. PMID: 22705954.
      Citations:    
    35. Safren SA, O'Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012 Jun; 80(3):404-15. PMID: 22545737.
      Citations:    
    36. Keough ME, Porter E, Kredlow MA, Worthington JJ, Hoge EA, Pollack MH, Shear MK, Simon NM. Anchoring the Panic Disorder Severity Scale. Assessment. 2012 Jun; 19(2):257-9. PMID: 22327206.
      Citations:    
    37. Hoge EA, Marques L, Wechsler RS, Lasky AK, Delong HR, Jacoby RJ, Worthington JJ, Pollack MH, Simon NM. The role of anxiety sensitivity in sleep disturbance in panic disorder. J Anxiety Disord. 2011 May; 25(4):536-8. PMID: 21277737.
      Citations:    
    38. Chandler GM, Iosifescu DV, Pollack MH, Targum SD, Fava M. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS Neurosci Ther. 2010 Oct; 16(5):322-5. PMID: 19769599.
      Citations:    
    39. Applebaum AJ, Bullis JR, Traeger LN, O'cleirigh C, Otto MW, Pollack MH, Safren SA. Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status. Neurobehav HIV Med. 2010 Aug 10; 2010(2):49-57. PMID: 24062619.
      Citations:    
    40. Hinton DE, Lewis-Fern?ndez R, Pollack MH. A model of the generation of ataque de nervios: the role of fear of negative affect and fear of arousal symptoms. CNS Neurosci Ther. 2009; 15(3):264-75. PMID: 19691546.
      Citations:    
    41. Hinton DE, Hofmann SG, Pollack MH, Otto MW. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009; 15(3):255-63. PMID: 19691545.
      Citations:    
    42. Hoge EA, Brandstetter K, Moshier S, Pollack MH, Wong KK, Simon NM. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety. 2009; 26(5):447-55. PMID: 19319993.
      Citations:    
    43. Marques L, Kaufman RE, LeBeau RT, Moshier SJ, Otto MW, Pollack MH, Simon NM. A comparison of emotional approach coping (EAC) between individuals with anxiety disorders and nonanxious controls. CNS Neurosci Ther. 2009; 15(2):100-6. PMID: 19492991.
      Citations:    
    44. Davidson J, Allgulander C, Pollack MH, Hartford J, Erickson JS, Russell JM, Perahia D, Wohlreich MM, Carlson J, Raskin J. Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. Hum Psychopharmacol. 2008 Aug; 23(6):519-26. PMID: 18478624.
      Citations:    
    45. Pollack MH, Tiller J, Xie F, Trivedi MH. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. J Clin Psychopharmacol. 2008 Jun; 28(3):308-16. PMID: 18480688.
      Citations:    
    46. George MS, Ward HE, Ninan PT, Pollack M, Nahas Z, Anderson B, Kose S, Howland RH, Goodman WK, Ballenger JC. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21. PMID: 20633378.
      Citations:    
    47. Simon NM, Connor KM, Lang AJ, Rauch S, Krulewicz S, LeBeau RT, Davidson JR, Stein MB, Otto MW, Foa EB, Pollack MH. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar; 69(3):400-5. PMID: 18348595.
      Citations:    
    48. Pollack MH. Changing times at CNS Neuroscience & Therapeutics. CNS Neurosci Ther. 2008; 14(1):1. PMID: 18482093.
      Citations:    
    49. Hinton DE, Chong R, Pollack MH, Barlow DH, McNally RJ. Ataque de nervios: relationship to anxiety sensitivity and dissociation predisposition. Depress Anxiety. 2008; 25(6):489-95. PMID: 17570492.
      Citations:    
    50. Pollack MH, Otto MW, Roy-Byrne PP, Coplan JD, Rothbaum BO, Simon NM, Gorman JM. Novel treatment approaches for refractory anxiety disorders. Depress Anxiety. 2008; 25(6):467-76. PMID: 17437259.
      Citations:    
    51. Targum SD, Pollack MH, Fava M. Redefining affective disorders: relevance for drug development. CNS Neurosci Ther. 2008; 14(1):2-9. PMID: 18482094.
      Citations:    
    52. Hinton DE, Hofmann SG, Pitman RK, Pollack MH, Barlow DH. The panic attack-posttraumatic stress disorder model: applicability to orthostatic panic among Cambodian refugees. Cogn Behav Ther. 2008; 37(2):101-16. PMID: 18470741.
      Citations:    
    53. Hinton DE, Hinton L, Tran M, Nguyen M, Nguyen L, Hsia C, Pollack MH. Orthostatic panic attacks among Vietnamese refugees. Transcult Psychiatry. 2007 Dec; 44(4):515-44. PMID: 18089637.
      Citations:    
    54. Taylor CT, Hirshfeld-Becker DR, Ostacher MJ, Chow CW, LeBeau RT, Pollack MH, Nierenberg AA, Simon NM. Anxiety is associated with impulsivity in bipolar disorder. J Anxiety Disord. 2008 Jun; 22(5):868-76. PMID: 17936573.
      Citations:    
    55. Pollack M, Mangano R, Entsuah R, Tzanis E, Simon NM, Zhang Y. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology (Berl). 2007 Oct; 194(2):233-42. PMID: 17589833.
      Citations:    
    56. Jhaveri M, Seal B, Pollack M, Wertz D. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. Curr Med Res Opin. 2007 Jun; 23(6):1431-43. PMID: 17559740.
      Citations:    
    57. Blier P, Keller MB, Pollack MH, Thase ME, Zajecka JM, Dunner DL. Preventing recurrent depression: long-term treatment for major depressive disorder. J Clin Psychiatry. 2007 Mar; 68(3):e06. PMID: 17388700.
      Citations:    
    58. Hoge EA, Austin ED, Pollack MH. Resilience: research evidence and conceptual considerations for posttraumatic stress disorder. Depress Anxiety. 2007; 24(2):139-52. PMID: 16892420.
      Citations:    
    59. Simon NM, Weiss AM, Kradin R, Evans KC, Reese HE, Otto MW, Oppenheimer JE, Smoller JW, Zalta A, Worthington JJ, Pollack MH. The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance. J Nerv Ment Dis. 2006 Dec; 194(12):951-7. PMID: 17164635.
      Citations:    
    60. Smoller JW, Pollack MH, Wassertheil-Smoller S, Brunner R, Curb D, Torner J, Oberman A, Hendrix SL, Hsia J, Sheps DS. Panic attacks, daily life ischemia, and chest pain in postmenopausal women. Psychosom Med. 2006 Nov-Dec; 68(6):824-32. PMID: 17101813.
      Citations:    
    61. Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu K, Weiss RD, Miyahara S, Thas ME, Sachs GS, Pollack MH. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006 Jul; 189:20-5. PMID: 16816301.
      Citations:    
    62. Hinton DE, Chhean D, Pich V, Pollack MH, Orr SP, Pitman RK. Assessment of posttraumatic stress disorder in Cambodian refugees using the Clinician-Administered PTSD Scale: psychometric properties and symptom severity. J Trauma Stress. 2006 Jun; 19(3):405-9. PMID: 16788999.
      Citations:    
    63. Gruber SA, Tzilos GK, Silveri MM, Pollack M, Renshaw PF, Kaufman MJ, Yurgelun-Todd DA. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol. 2006 May; 14(2):157-64. PMID: 16756419.
      Citations:    
    64. Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M, Wong KK. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry. 2006 Sep 01; 60(5):432-5. PMID: 16581033.
      Citations:    
    65. Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006 Mar; 63(3):298-304. PMID: 16520435.
      Citations:    
    66. Simon NM, Hoge EA, Fischmann D, Worthington JJ, Christian KM, Kinrys G, Pollack MH. An open-label trial of risperidone augmentation for refractory anxiety disorders. J Clin Psychiatry. 2006 Mar; 67(3):381-5. PMID: 16649823.
      Citations:    
    67. Hinton DE, Pich V, Chhean D, Safren SA, Pollack MH. Somatic-focused therapy for traumatized refugees: Treating posttraumatic stress disorder and comorbid neck-focused panic attacks among cambodian refugees. Psychotherapy (Chic). 2006; 43(4):491-505. PMID: 22122139.
      Citations:    
    68. Hinton DE, Chhean D, Pich V, Um K, Fama JM, Pollack MH. Neck-focused panic attacks among Cambodian refugees; a logistic and linear regression analysis. J Anxiety Disord. 2006; 20(2):119-38. PMID: 16464700.
      Citations:    
    69. Simon NM, Zalta AK, Worthington JJ, Hoge EA, Christian KM, Stevens JC, Pollack MH. Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder. Depress Anxiety. 2006; 23(6):373-6. PMID: 17068858.
      Citations:    
    70. Lyoo IK, Pollack MH, Silveri MM, Ahn KH, Diaz CI, Hwang J, Kim SJ, Yurgelun-Todd DA, Kaufman MJ, Renshaw PF. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl). 2006 Jan; 184(2):139-44. PMID: 16369836.
      Citations:    
    71. Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. J Clin Psychiatry. 2005 Nov; 66(11):1401-8. PMID: 16420077.
      Citations:    
    72. Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry. 2005 Sep; 62(9):1022-30. PMID: 16143734.
      Citations:    
    73. Simon NM, Pollack MH, Fischmann D, Perlman CA, Muriel AC, Moore CW, Nierenberg AA, Shear MK. Complicated grief and its correlates in patients with bipolar disorder. J Clin Psychiatry. 2005 Sep; 66(9):1105-10. PMID: 16187766.
      Citations:    
    74. Simon NM, Otto MW, Fischmann D, Racette S, Nierenberg AA, Pollack MH, Smoller JW. Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states. J Affect Disord. 2005 Jul; 87(1):101-5. PMID: 15894380.
      Citations:    
    75. Stevens JC, Pollack MH. Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents. J Clin Psychiatry. 2005; 66 Suppl 2:21-7. PMID: 15762816.
      Citations:    
    76. Pollack MH. Comorbid anxiety and depression. J Clin Psychiatry. 2005; 66 Suppl 8:22-9. PMID: 16336033.
      Citations:    
    77. Hinton DE, Pich V, Chhean D, Pollack MH, McNally RJ. Sleep paralysis among Cambodian refugees: association with PTSD diagnosis and severity. Depress Anxiety. 2005; 22(2):47-51. PMID: 16094659.
      Citations:    
    78. Worthington JJ, Kinrys G, Wygant LE, Pollack MH. Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacol. 2005 Jan; 20(1):9-11. PMID: 15602109.
      Citations:    
    79. Hinton DE, Pham T, Tran M, Safren SA, Otto MW, Pollack MH. CBT for Vietnamese refugees with treatment-resistant PTSD and panic attacks: a pilot study. J Trauma Stress. 2004 Oct; 17(5):429-33. PMID: 15633922.
      Citations:    
    80. Lyoo IK, Streeter CC, Ahn KH, Lee HK, Pollack MH, Silveri MM, Nassar L, Levin JM, Sarid-Segal O, Ciraulo DA, Renshaw PF, Kaufman MJ. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res. 2004 Jul 30; 131(2):135-45. PMID: 15313520.
      Citations:    
    81. Stein MB, Pollack MH, Bystritsky A, Kelsey JE, Mangano RM. Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial. Psychopharmacology (Berl). 2005 Jan; 177(3):280-8. PMID: 15258718.
      Citations:    
    82. Hinton D, Pich V, Chhean D, Pollack M. Olfactory-triggered panic attacks among Khmer refugees: a contextual approach. Transcult Psychiatry. 2004 Jun; 41(2):155-99. PMID: 15446720.
      Citations:    
    83. Biederman J, Petty C, Faraone SV, Hirshfeld-Becker D, Pollack MH, Henin A, Gilbert J, Rosenbaum JF. Moderating effects of major depression on patterns of comorbidity in patients with panic disorder. Psychiatry Res. 2004 Apr 30; 126(2):143-9. PMID: 15123393.
      Citations:    
    84. Otto MW, Safren SA, Pollack MH. Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder. J Anxiety Disord. 2004; 18(1):69-87. PMID: 14725869.
      Citations:    
    85. Pollack MH. Unmet needs in the treatment of anxiety disorders. Psychopharmacol Bull. 2004; 38(1):31-7. PMID: 15278016.
      Citations:    
    86. Otto MW, Hinton D, Korbly NB, Chea A, Ba P, Gershuny BS, Pollack MH. Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone. Behav Res Ther. 2003 Nov; 41(11):1271-6. PMID: 14527527.
      Citations:    
    87. Pollack MH, Simon NM, Worthington JJ, Doyle AL, Peters P, Toshkov F, Otto MW. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol. 2003 Sep; 17(3):276-82. PMID: 14513919.
      Citations:    
    88. Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, Nutt DJ, Okasha A, Swinson RP. WCA recommendations for the long-term treatment of panic disorder. CNS Spectr. 2003 Aug; 8(8 Suppl 1):17-30. PMID: 14767395.
      Citations:    
    89. Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP. WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr. 2003 Aug; 8(8 Suppl 1):53-61. PMID: 14767398.
      Citations:    
    90. Manfro GG, Isolan L, Blaya C, Maltz S, Heldt E, Pollack MH. Relationship between adult social phobia and childhood anxiety. Braz J Psychiatry. 2003 Jun; 25(2):96-9. PMID: 12975706.
      Citations:    
    91. Pollack MH, Meoni P, Otto MW, Simon N, Hackett D. Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies. J Clin Psychopharmacol. 2003 Jun; 23(3):250-9. PMID: 12826987.
      Citations:    
    92. Kinrys G, Pollack MH, Simon NM, Worthington JJ, Nardi AE, Versiani M. Valproic acid for the treatment of social anxiety disorder. Int Clin Psychopharmacol. 2003 May; 18(3):169-72. PMID: 12702897.
      Citations:    
    93. Manfro GG, Alexandre Netto C, Pollack M, Mezzomo KM, Preffer F, Kradin R. Stress regulates the lymphocyte homing receptor CD62L (L-selectin). Arq Neuropsiquiatr. 2003 Mar; 61(1):20-4. PMID: 12715014.
      Citations:    
    94. Hagengimana A, Hinton D, Bird B, Pollack M, Pitman RK. Somatic panic-attack equivalents in a community sample of Rwandan widows who survived the 1994 genocide. Psychiatry Res. 2003 Jan 25; 117(1):1-9. PMID: 12581815.
      Citations:    
    95. Pollack MH, Doyle AC. Treatment of panic disorder: focus on paroxetine. Psychopharmacol Bull. 2003; 37 Suppl 1:53-63. PMID: 14566201.
      Citations:    
    96. Pollack MH, Penava SA, Bolton E, Worthington JJ, Allen GL, Farach FJ, Otto MW. A novel cognitive-behavioral approach for treatment-resistant drug dependence. J Subst Abuse Treat. 2002 Dec; 23(4):335-42. PMID: 12495795.
      Citations:    
    97. Worthington JJ, Simon NM, Korbly NB, Perlis RH, Pollack MH. Ropinirole for antidepressant-induced sexual dysfunction. Int Clin Psychopharmacol. 2002 Nov; 17(6):307-10. PMID: 12409684.
      Citations:    
    98. Simon NM, Otto MW, Korbly NB, Peters PM, Nicolaou DC, Pollack MH. Quality of life in social anxiety disorder compared with panic disorder and the general population. Psychiatr Serv. 2002 Jun; 53(6):714-8. PMID: 12045308.
      Citations:    
    99. Simon NM, Blacker D, Korbly NB, Sharma SG, Worthington JJ, Otto MW, Pollack MH. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. J Affect Disord. 2002 May; 69(1-3):209-17. PMID: 12103468.
      Citations:    
    100. Huffman JC, Pollack MH, Stern TA. Panic Disorder and Chest Pain: Mechanisms, Morbidity, and Management. Prim Care Companion J Clin Psychiatry. 2002 Apr; 4(2):54-62. PMID: 15014745.
      Citations:    
    101. Blais MA, Otto MW, Zucker BG, McNally RJ, Schmidt NB, Fava M, Pollack MH. The anxiety sensitivity index: item analysis and suggestions for refinement. J Pers Assess. 2001 Oct; 77(2):272-94. PMID: 11693859.
      Citations:    
    102. Rapaport MH, Wolkow R, Rubin A, Hackett E, Pollack M, Ota KY. Sertraline treatment of panic disorder: results of a long-term study. Acta Psychiatr Scand. 2001 Oct; 104(4):289-98. PMID: 11722304.
      Citations:    
    103. Rapaport MH, Pollack MH, Clary CM, Mardekian J, Wolkow R. Panic disorder and response to sertraline: the effect of previous treatment with benzodiazepines. J Clin Psychopharmacol. 2001 Feb; 21(1):104-7. PMID: 11199932.
      Citations:    
    104. Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW, Pollack MH, Chandler L, Williams J, Ali A, Frank DM. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety. 2001; 13(4):166-78. PMID: 11413563.
      Citations:    
    105. Pollack MH. Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission. J Clin Psychiatry. 2001; 62 Suppl 19:20-5. PMID: 11577787.
      Citations:    
    106. Uhlenhuth EH, Matuzas W, Warner TD, Paine S, Lydiard RB, Pollack MH. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication. J Clin Psychopharmacol. 2000 Dec; 20(6):622-7. PMID: 11106133.
      Citations:    
    107. Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, Lydiard RB, Taylor CB, Dager SR, Shiovitz T. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000 Aug; 20(4):467-71. PMID: 10917408.
      Citations:    
    108. Marzol PC, Pollack MH. New developments in panic disorder. Curr Psychiatry Rep. 2000 Aug; 2(4):353-7. PMID: 11122981.
      Citations:    
    109. Otto MW, Pollack MH, Gould RA, Worthington JJ, McArdle ET, Rosenbaum JF. A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. J Anxiety Disord. 2000 Jul-Aug; 14(4):345-58. PMID: 11043885.
      Citations:    
    110. Fones CS, Pollack MH, Susswein L, Otto M. History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. J Affect Disord. 2000 May; 58(2):99-106. PMID: 10781699.
      Citations:    
    111. Pollack MH, Marzol PC. Panic: course, complications and treatment of panic disorder. J Psychopharmacol. 2000; 14(2 Suppl 1):S25-30. PMID: 10888028.
      Citations:    
    112. Scott EL, Pollack MH, Otto MW, Simon NM, Worthington JJ. Clinician response to treatment refractory panic disorder: a survey of psychiatrists. J Nerv Ment Dis. 1999 Dec; 187(12):755-7. PMID: 10665472.
      Citations:    
    113. Otto MW, Pollack MH, Penava SJ, Zucker BG. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther. 1999 Aug; 37(8):763-70. PMID: 10452176.
      Citations:    
    114. Candilis PJ, McLean RY, Otto MW, Manfro GG, Worthington JJ, Penava SJ, Marzol PC, Pollack MH. Quality of life in patients with panic disorder. J Nerv Ment Dis. 1999 Jul; 187(7):429-34. PMID: 10426463.
      Citations:    
    115. Smoller JW, Simon NM, Pollack MH, Kradin R, Stern T. Anxiety in patients with pulmonary disease: comorbidity and treatment. Semin Clin Neuropsychiatry. 1999 Apr; 4(2):84-97. PMID: 10378952.
      Citations:    
    116. Penava SJ, Otto MW, Maki KM, Pollack MH. Rate of improvement during cognitive-behavioral group treatment for panic disorder. Behav Res Ther. 1998 Jul-Aug; 36(7-8):665-73. PMID: 9682523.
      Citations:    
    117. Pollack MH, Matthews J, Scott EL. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry. 1998 Jul; 155(7):992-3. PMID: 9659873.
      Citations:    
    118. Smoller JW, McLean RY, Otto MW, Pollack MH. How do clinicians respond to patients who miss appointments? J Clin Psychiatry. 1998 Jun; 59(6):330-8; quiz 339-40. PMID: 9671351.
      Citations:    
    119. Simon NM, Pollack MH, Tuby KS, Stern TA. Dizziness and panic disorder: a review of the association between vestibular dysfunction and anxiety. Ann Clin Psychiatry. 1998 Jun; 10(2):75-80. PMID: 9669539.
      Citations:    
    120. Otto MW, Demopulos CM, McLean NE, Pollack MH, Fava M. Additional findings on the association between anxiety sensitivity and hypochondriacal concerns: examination of patients with major depression. J Anxiety Disord. 1998 May-Jun; 12(3):225-32. PMID: 9653681.
      Citations:    
    121. Worthington JJ, Pollack MH, Otto MW, McLean RY, Moroz G, Rosenbaum JF. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull. 1998; 34(2):199-205. PMID: 9641001.
      Citations:    
    122. Worthington JJ, Zucker BG, Fones CS, Otto MW, Pollack MH. Nefazodone for social phobia: a clinical case series. Depress Anxiety. 1998; 8(3):131-3. PMID: 9836065.
      Citations:    
    123. Fones CS, Manfro GG, Pollack MH. Social phobia: an update. Harv Rev Psychiatry. 1998 Jan-Feb; 5(5):247-59. PMID: 9493947.
      Citations:    
    124. Bloch Y, Pollack M, Mor I. Should the administration of ECT during clozapine therapy be contraindicated? Br J Psychiatry. 1996 Aug; 169(2):253-4. PMID: 8871811.
      Citations:    
    125. Rosenbaum JF, Pollock RA, Jordan SK, Pollack MH. The pharmacotherapy of panic disorder. Bull Menninger Clin. 1996; 60(2 Suppl A):A54-75. PMID: 8857427.
      Citations:    
    126. Penava SJ, Otto MW, Pollack MH, Rosenbaum JF. Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies. Depress Anxiety. 1996-1997; 4(5):240-2. PMID: 9167791.
      Citations:    
    127. Weilburg JB, Schachter S, Worth J, Pollack MH, Sachs GS, Ives JR, Schomer DL. EEG abnormalities in patients with atypical panic attacks. J Clin Psychiatry. 1995 Aug; 56(8):358-62. PMID: 7635852.
      Citations:    
    128. Otto MW, Pollack MH, Ball SG, Rosenbaum JF. Integration of behavioral and pharmacological treatments for panic disorder: implications for the treatment of substance dependence. NIDA Res Monogr. 1995; 150:143-66. PMID: 8742777.
      Citations:    
    129. Shear MK, Leon AC, Pollack MH, Rosenbaum JF, Keller MB. Pattern of placebo response in panic disorder. Psychopharmacol Bull. 1995; 31(2):273-8. PMID: 7491379.
      Citations:    
    130. Otto MW, McNally RJ, Pollack MH, Chen E, Rosenbaum JF. Hemispheric laterality and memory bias for threat in anxiety disorders. J Abnorm Psychol. 1994 Nov; 103(4):828-831. PMID: 7822587.
      Citations:    
    131. Labbate LA, Pollack MH, Otto MW, Tesar GM, Rosenbaum JF. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. J Clin Psychopharmacol. 1994 Aug; 14(4):274-6. PMID: 7962684.
      Citations:    
    132. Pollack MH, Otto MW, Sachs GS, Leon A, Shear MK, Deltito JA, Keller MB, Rosenbaum JF. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord. 1994 Apr; 30(4):273-81. PMID: 8014326.
      Citations:    
    133. Labbate LA, Pollack MH. Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Ann Clin Psychiatry. 1994 Mar; 6(1):13-5. PMID: 7951639.
      Citations:    
    134. Otto MW, Pollack MH, Rosenbaum JF, Sachs GS, Asher RH. Childhood history of anxiety in adults with panic disorder: association with anxiety sensitivity and comorbidity. Harv Rev Psychiatry. 1994 Jan-Feb; 1(5):288-93. PMID: 9384860.
      Citations:    
    135. Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K, et al. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord. 1993 May; 28(1):27-38. PMID: 8326078.
      Citations:    
    136. Pollack MH, Otto MW, Rosenbaum JF, Sachs GS. Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity. Compr Psychiatry. 1992 Mar-Apr; 33(2):78-83. PMID: 1544300.
      Citations:    
    137. Pollack MH, Reiter S, Hammerness P. Genitourinary and sexual adverse effects of psychotropic medication. Int J Psychiatry Med. 1992; 22(4):305-27. PMID: 1363418.
      Citations:    
    138. Tesar GE, Rosenbaum JF, Pollack MH, Otto MW, Sachs GS, Herman JB, Cohen LS, Spier SA. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry. 1991 Feb; 52(2):69-76. PMID: 1993639.
      Citations:    
    139. Pollack MH. Long-term management of panic disorder. J Clin Psychiatry. 1990 May; 51 Suppl:11-3; discussion 50-3. PMID: 1970813.
      Citations:    
    140. Rosenbaum JF, Fava M, Falk WE, Pollack MH, Cohen LS, Cohen BM, Zubenko GS. The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatr Scand. 1990 May; 81(5):432-6. PMID: 2113347.
      Citations:    
    141. Mahoney JD, Gross PL, Stern TA, Browne BJ, Pollack MH, Reder V, Mulley AG. Quantitative serum toxic screening in the management of suspected drug overdose. Am J Emerg Med. 1990 Jan; 8(1):16-22. PMID: 2293827.
      Citations:    
    142. Herman JB, Brotman AW, Pollack MH, Falk WE, Biederman J, Rosenbaum JF. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry. 1990 Jan; 51(1):25-7. PMID: 2295587.
      Citations:    
    143. Weilburg JB, Rosenbaum JF, Biederman J, Sachs GS, Pollack MH, Kelly K. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9. PMID: 2600061.
      Citations:    
    144. Pollack M, Chia JK, Koles NL, Miller M, Guelde G. Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide. J Infect Dis. 1989 Feb; 159(2):168-88. PMID: 2915151.
      Citations:    
    145. Pollack MH, Brotman AW, Rosenbaum JF. Cocaine abuse and treatment. Compr Psychiatry. 1989 Jan-Feb; 30(1):31-44. PMID: 2647400.
      Citations:    
    146. Rosenbaum JF, Fava M, Falk WE, Pollack MH, Cohen LS, Cohen BM, Zubenko GS. An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results. Psychopharmacol Bull. 1988; 24(1):189-94. PMID: 3387521.
      Citations:    
    147. Pollack MH. Clonazepam: a review of open clinical trials. J Clin Psychiatry. 1987 Oct; 48 Suppl:12-5. PMID: 3312178.
      Citations:    
    148. Tesar GE, Rosenbaum JF, Biederman J, Weilburg JB, Pollack MH, Gross CC, Falk WE, Gastfriend DR, Zusky PM, Bouckoms A. Orthostatic hypotension and antidepressant pharmacotherapy. Psychopharmacol Bull. 1987; 23(1):182-6. PMID: 3602317.
      Citations:    
    149. Pollack MH, Rosenbaum JF, Tesar GE, Herman JB, Sachs GS. Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol Bull. 1987; 23(1):141-4. PMID: 3110854.
      Citations:    
    150. Weilburg JB, Pollack M, Murray GB, Garber HJ. On panic attacks and neurologic problems. Am J Psychiatry. 1986 Dec; 143(12):1626-7. PMID: 3789218.
      Citations:    
    151. Pollack MH, Tesar GE, Rosenbaum JF, Spier SA. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J Clin Psychopharmacol. 1986 Oct; 6(5):302-4. PMID: 3771814.
      Citations:    
    152. Levine LS, Dupont B, Lorenzen F, Pang S, Pollack M, Oberfield S, Kohn B, Lerner A, Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F, New MI. Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1980 Dec; 51(6):1316-24. PMID: 6449518.
      Citations:    
    153. Woerner MG, Pollack M, Klein DF. Birth weight and length in schizophrenics personality disorders and their siblings. Br J Psychiatry. 1971 Apr; 118(545):461-4. PMID: 5576647.
      Citations:    
    154. Pollack M, Woerner MG, Goldberg P, Klein DF. Siblings of schizophrenic and nonschizophrenic psychiatric patients. Psychopathology and gender concordance. Arch Gen Psychiatry. 1969 Jun; 20(6):652-8. PMID: 5772542.
      Citations:    
    155. Levenstein S, Klein DF, Pollack M. Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years. Am J Psychiatry. 1966 Apr; 122(10):1102-9. PMID: 5909001.
      Citations:    
    156. BELMONT I, BIRCH HG, KLEIN DF, POLLACK M, OAKS G. PERCEPTUAL EVIDENCE OF CNS DYSFUNCTION IN SCHIZOPHRENIA. Arch Gen Psychiatry. 1964 Apr; 10:395-408. PMID: 14106964.
      Citations:    
    157. FINK M, KAHN RL, KARP E, POLLACK M, GREEN MA, ALAN B, EFKOWITS HJ. Inhalant-induced convulsions. Significance for the theory of the convulsive therapy process. Arch Gen Psychiatry. 1961 Mar; 4:259-66. PMID: 13699611.
      Citations:    
    Pollack's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (466)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _